The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Epinephrine Autoinjector Market Research Report 2024
Synopsis
Epinephrine is the only treatment for a severe allergic reaction known as anaphylaxis (anna-fih-LACK-sis). Epinephrine comes in the form of easy-to-use auto-injectors. It is only available through a prescription by doctors. Each prescription comes with two auto-injectors in a set.
Epinephrine auto-injector is an emergency injection ("shot") of epinephrine. It is used against life-threatening allergic reactions such as severe swelling, breathing problems, or loss of blood pressure.
The global Epinephrine Autoinjector market was valued at US$ 2161 million in 2023 and is anticipated to reach US$ 3489.4 million by 2030, witnessing a CAGR of 7.0% during the forecast period 2024-2030.
Global Epinephrine Autoinjector key players include Mylan, Amneal pharma, Kaleo, etc. Global top three players hold a share about 25%.
North America is the largest market, with a share about 70%, followed by Europe and Asia-Pacific, having a total share about 25 percent.
In terms of product, 0.15 mg is the largest segment, with a share about 65%. And in terms of application, the largest application is people who are Under 6 Years, followed by people who are 6 to 12 Years and Over 12 Years.
This report aims to provide a comprehensive presentation of the global market for Epinephrine Autoinjector, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epinephrine Autoinjector.
Report Scope
The Epinephrine Autoinjector market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Epinephrine Autoinjector market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Epinephrine Autoinjector manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mylan
Sanofi
ALK Abello
Impax
Segment by Type
0.30 mg
0.15 mg
Segment by Application
Under 6 Years
6 to 12 Years
Over 12 Years
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Epinephrine Autoinjector manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Epinephrine Autoinjector in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Epinephrine is the only treatment for a severe allergic reaction known as anaphylaxis (anna-fih-LACK-sis). Epinephrine comes in the form of easy-to-use auto-injectors. It is only available through a prescription by doctors. Each prescription comes with two auto-injectors in a set.
Epinephrine auto-injector is an emergency injection ("shot") of epinephrine. It is used against life-threatening allergic reactions such as severe swelling, breathing problems, or loss of blood pressure.
The global Epinephrine Autoinjector market was valued at US$ 2161 million in 2023 and is anticipated to reach US$ 3489.4 million by 2030, witnessing a CAGR of 7.0% during the forecast period 2024-2030.
Global Epinephrine Autoinjector key players include Mylan, Amneal pharma, Kaleo, etc. Global top three players hold a share about 25%.
North America is the largest market, with a share about 70%, followed by Europe and Asia-Pacific, having a total share about 25 percent.
In terms of product, 0.15 mg is the largest segment, with a share about 65%. And in terms of application, the largest application is people who are Under 6 Years, followed by people who are 6 to 12 Years and Over 12 Years.
This report aims to provide a comprehensive presentation of the global market for Epinephrine Autoinjector, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epinephrine Autoinjector.
Report Scope
The Epinephrine Autoinjector market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Epinephrine Autoinjector market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Epinephrine Autoinjector manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mylan
Sanofi
ALK Abello
Impax
Segment by Type
0.30 mg
0.15 mg
Segment by Application
Under 6 Years
6 to 12 Years
Over 12 Years
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Epinephrine Autoinjector manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Epinephrine Autoinjector in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Epinephrine Autoinjector Market Overview
1.1 Product Overview and Scope of Epinephrine Autoinjector
1.2 Epinephrine Autoinjector Segment by Type
1.2.1 Global Epinephrine Autoinjector Market Value Comparison by Type (2024-2030)
1.2.2 0.30 mg
1.2.3 0.15 mg
1.3 Epinephrine Autoinjector Segment by Application
1.3.1 Global Epinephrine Autoinjector Market Value by Application: (2024-2030)
1.3.2 Under 6 Years
1.3.3 6 to 12 Years
1.3.4 Over 12 Years
1.4 Global Epinephrine Autoinjector Market Size Estimates and Forecasts
1.4.1 Global Epinephrine Autoinjector Revenue 2019-2030
1.4.2 Global Epinephrine Autoinjector Sales 2019-2030
1.4.3 Global Epinephrine Autoinjector Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Epinephrine Autoinjector Market Competition by Manufacturers
2.1 Global Epinephrine Autoinjector Sales Market Share by Manufacturers (2019-2024)
2.2 Global Epinephrine Autoinjector Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Epinephrine Autoinjector Average Price by Manufacturers (2019-2024)
2.4 Global Epinephrine Autoinjector Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Epinephrine Autoinjector, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Epinephrine Autoinjector, Product Type & Application
2.7 Epinephrine Autoinjector Market Competitive Situation and Trends
2.7.1 Epinephrine Autoinjector Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Epinephrine Autoinjector Players Market Share by Revenue
2.7.3 Global Epinephrine Autoinjector Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Epinephrine Autoinjector Retrospective Market Scenario by Region
3.1 Global Epinephrine Autoinjector Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Epinephrine Autoinjector Global Epinephrine Autoinjector Sales by Region: 2019-2030
3.2.1 Global Epinephrine Autoinjector Sales by Region: 2019-2024
3.2.2 Global Epinephrine Autoinjector Sales by Region: 2025-2030
3.3 Global Epinephrine Autoinjector Global Epinephrine Autoinjector Revenue by Region: 2019-2030
3.3.1 Global Epinephrine Autoinjector Revenue by Region: 2019-2024
3.3.2 Global Epinephrine Autoinjector Revenue by Region: 2025-2030
3.4 North America Epinephrine Autoinjector Market Facts & Figures by Country
3.4.1 North America Epinephrine Autoinjector Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Epinephrine Autoinjector Sales by Country (2019-2030)
3.4.3 North America Epinephrine Autoinjector Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Epinephrine Autoinjector Market Facts & Figures by Country
3.5.1 Europe Epinephrine Autoinjector Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Epinephrine Autoinjector Sales by Country (2019-2030)
3.5.3 Europe Epinephrine Autoinjector Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Epinephrine Autoinjector Market Facts & Figures by Country
3.6.1 Asia Pacific Epinephrine Autoinjector Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Epinephrine Autoinjector Sales by Country (2019-2030)
3.6.3 Asia Pacific Epinephrine Autoinjector Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Epinephrine Autoinjector Market Facts & Figures by Country
3.7.1 Latin America Epinephrine Autoinjector Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Epinephrine Autoinjector Sales by Country (2019-2030)
3.7.3 Latin America Epinephrine Autoinjector Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Epinephrine Autoinjector Market Facts & Figures by Country
3.8.1 Middle East and Africa Epinephrine Autoinjector Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Epinephrine Autoinjector Sales by Country (2019-2030)
3.8.3 Middle East and Africa Epinephrine Autoinjector Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Epinephrine Autoinjector Sales by Type (2019-2030)
4.1.1 Global Epinephrine Autoinjector Sales by Type (2019-2024)
4.1.2 Global Epinephrine Autoinjector Sales by Type (2025-2030)
4.1.3 Global Epinephrine Autoinjector Sales Market Share by Type (2019-2030)
4.2 Global Epinephrine Autoinjector Revenue by Type (2019-2030)
4.2.1 Global Epinephrine Autoinjector Revenue by Type (2019-2024)
4.2.2 Global Epinephrine Autoinjector Revenue by Type (2025-2030)
4.2.3 Global Epinephrine Autoinjector Revenue Market Share by Type (2019-2030)
4.3 Global Epinephrine Autoinjector Price by Type (2019-2030)
5 Segment by Application
5.1 Global Epinephrine Autoinjector Sales by Application (2019-2030)
5.1.1 Global Epinephrine Autoinjector Sales by Application (2019-2024)
5.1.2 Global Epinephrine Autoinjector Sales by Application (2025-2030)
5.1.3 Global Epinephrine Autoinjector Sales Market Share by Application (2019-2030)
5.2 Global Epinephrine Autoinjector Revenue by Application (2019-2030)
5.2.1 Global Epinephrine Autoinjector Revenue by Application (2019-2024)
5.2.2 Global Epinephrine Autoinjector Revenue by Application (2025-2030)
5.2.3 Global Epinephrine Autoinjector Revenue Market Share by Application (2019-2030)
5.3 Global Epinephrine Autoinjector Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Mylan
6.1.1 Mylan Corporation Information
6.1.2 Mylan Description and Business Overview
6.1.3 Mylan Epinephrine Autoinjector Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Mylan Epinephrine Autoinjector Product Portfolio
6.1.5 Mylan Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Epinephrine Autoinjector Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Epinephrine Autoinjector Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 ALK Abello
6.3.1 ALK Abello Corporation Information
6.3.2 ALK Abello Description and Business Overview
6.3.3 ALK Abello Epinephrine Autoinjector Sales, Revenue and Gross Margin (2019-2024)
6.3.4 ALK Abello Epinephrine Autoinjector Product Portfolio
6.3.5 ALK Abello Recent Developments/Updates
6.4 Impax
6.4.1 Impax Corporation Information
6.4.2 Impax Description and Business Overview
6.4.3 Impax Epinephrine Autoinjector Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Impax Epinephrine Autoinjector Product Portfolio
6.4.5 Impax Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Epinephrine Autoinjector Industry Chain Analysis
7.2 Epinephrine Autoinjector Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Epinephrine Autoinjector Production Mode & Process
7.4 Epinephrine Autoinjector Sales and Marketing
7.4.1 Epinephrine Autoinjector Sales Channels
7.4.2 Epinephrine Autoinjector Distributors
7.5 Epinephrine Autoinjector Customers
8 Epinephrine Autoinjector Market Dynamics
8.1 Epinephrine Autoinjector Industry Trends
8.2 Epinephrine Autoinjector Market Drivers
8.3 Epinephrine Autoinjector Market Challenges
8.4 Epinephrine Autoinjector Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
